Related Experiment Videos
Actinomycin D oxazinones as improved antitumor agents.
Journal of Medicinal Chemistry
|July 1, 1979
Summary
New actinomycin D (AMD) derivatives, 1,4-oxazinones, were synthesized. These compounds act as depot forms of AMD, showing enhanced antitumor activity and reduced toxicity against P388 mouse leukemia.
Area of Science:
- Medicinal Chemistry
- Organic Synthesis
- Pharmacology
Background:
- Actinomycin D (AMD) is a potent anticancer agent.
- The phenoxazinone chromophore is central to AMD's activity.
- Modifications to AMD's structure are explored to improve its therapeutic index.
Purpose of the Study:
- To synthesize novel 1,4-oxazinone derivatives of actinomycin D.
- To investigate the physicochemical and DNA-binding properties of these derivatives.
- To evaluate the antitumor activity and toxicity of the synthesized compounds.
Main Methods:
- Synthesis of 1,4-oxazinone derivatives via condensation of AMD with alpha-keto acids.
- Alteration of molecular lipophilicity by varying alpha-keto acid substituents.
- Assessment of in vitro and in vivo antitumor activity against P388 mouse leukemia.
- Evaluation of toxicity profiles compared to AMD.
Main Results:
- Novel 1,4-oxazinone derivatives of AMD were successfully synthesized.
- These derivatives function as depot forms, releasing AMD in physiological media.
- Oxazinones with bulky, lipophilic substituents exhibited enhanced antitumor efficacy.
- The synthesized oxazinones demonstrated reduced toxicity compared to parent AMD.
Conclusions:
- 1,4-Oxazinone derivatives represent promising prodrugs of actinomycin D.
- Structural modifications can significantly alter lipophilicity, DNA-binding, and therapeutic properties.
- These novel compounds offer a potentially improved therapeutic strategy for cancer treatment.